MCQ: Neonatal thrombocytopenia
A term male neonate develops widespread petechiae and ecchymoses within 2 hours of birth. He is otherwise well, with no hepatosplenomegaly or dysmorphic features. Laboratory evaluation reveals a platelet count of 18,000/µL, while the hemoglobin and leukocyte counts are normal. The mother has a normal platelet count and no history of autoimmune disease. Cranial ultrasonography demonstrates a small intracranial hemorrhage. Which of the following is the most appropriate initial management?
A. Intravenous immunoglobulin (IVIG) with HPA-compatible platelet transfusion
B. Observation with repeat platelet count after 24 hours
C. Platelet transfusion from random donor platelets alone
D. Prednisolone therapy for the mother and infant
E. Exchange transfusion
Correct answer & Explanation:
Correct Answer
A. Intravenous immunoglobulin (IVIG) with HPA-compatible platelet transfusion
Explanation
Neonatal alloimmune thrombocytopenia (NAIT), also called fetal and neonatal alloimmune thrombocytopenia (FNAIT), results from maternal IgG antibodies directed against paternally inherited human platelet antigens (most commonly HPA-1a). These antibodies cross the placenta and destroy fetal platelets.
Typical features include:
- Severe thrombocytopenia (<30,000/µL) at birth
- Petechiae or purpura in an otherwise healthy term neonate
- Mother with a normal platelet count
- High risk of intracranial hemorrhage, which may occur antenatally or shortly after birth
In neonates with severe thrombocytopenia or bleeding, the recommended treatment is:
- Immediate transfusion of HPA-compatible (antigen-negative) platelets, ideally maternal washed platelets or HPA-matched donor platelets.
- Intravenous immunoglobulin (IVIG, 1 g/kg/day for 1–2 days) to reduce ongoing immune-mediated platelet destruction.
This combination rapidly increases the platelet count and reduces the risk of further bleeding.
Why the other options are incorrect
B. Observation with repeat platelet count after 24 hours
Incorrect. Severe thrombocytopenia with intracranial hemorrhage is a neonatal emergency requiring immediate treatment.
C. Platelet transfusion from random donor platelets alone
Incorrect. Random donor platelets may be rapidly destroyed because they usually express the target platelet antigen. They may be used only if HPA-compatible platelets are not immediately available but should not be considered the optimal treatment.
D. Prednisolone therapy for the mother and infant
Incorrect. Corticosteroids are not recommended as initial neonatal treatment for NAIT.
E. Exchange transfusion
Incorrect. Exchange transfusion has no established role in the routine management of NAIT.
Key Learning Point
A healthy term neonate with severe thrombocytopenia at birth and a mother with a normal platelet count should raise strong suspicion for neonatal alloimmune thrombocytopenia. Severe disease or bleeding requires urgent HPA-compatible platelet transfusion together with IVIG to reduce the risk of life-threatening hemorrhage.
References
- Nelson Textbook of Pediatrics, 22nd Edition.
- Cloherty & Stark’s Manual of Neonatal Care, 9th Edition.
- American Academy of Pediatrics (AAP) recommendations on neonatal thrombocytopenia.
- International Collaboration for Transfusion Medicine Guidelines (ICTMG) on Fetal and Neonatal Alloimmune Thrombocytopenia.
